AMSTERDAM, Jan 21 (Reuters) - Dutch fund ABP, the world's third biggest state pension fund after Japan's and Norway's, announced a new three-year investment plan on Thursday seeking to balance the ...
AEON Biopharma, Inc. announced in its press release that it is advancing its biosimilar development program for ABP-450, a botulinum toxin complex, by initiating analytical studies to prepare for a ...
IRVINE, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results